000 | 01733 a2200481 4500 | ||
---|---|---|---|
005 | 20250513055251.0 | ||
264 | 0 | _c19940818 | |
008 | 199408s 0 0 eng d | ||
022 | _a0022-1899 | ||
024 | 7 |
_a10.1093/infdis/170.2.479 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCambau, E | |
245 | 0 | 0 |
_aSelection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. _h[electronic resource] |
260 |
_bThe Journal of infectious diseases _cAug 1994 |
||
300 |
_a479-83 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
650 | 0 | 4 |
_aAspartic Acid _xchemistry |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aDNA Gyrase |
650 | 0 | 4 |
_aDNA Primers _xchemistry |
650 | 0 | 4 |
_aDNA Topoisomerases, Type II _xchemistry |
650 | 0 | 4 |
_aDNA, Bacterial _xchemistry |
650 | 0 | 4 |
_aDrug Resistance, Microbial _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHistidine _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMolecular Sequence Data |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 |
_aOfloxacin _xpharmacology |
650 | 0 | 4 | _aPoint Mutation |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
700 | 1 | _aSougakoff, W | |
700 | 1 | _aBesson, M | |
700 | 1 | _aTruffot-Pernot, C | |
700 | 1 | _aGrosset, J | |
700 | 1 | _aJarlier, V | |
773 | 0 |
_tThe Journal of infectious diseases _gvol. 170 _gno. 2 _gp. 479-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/170.2.479 _zAvailable from publisher's website |
999 |
_c8034369 _d8034369 |